Skip to main content
. 2011 Jan 24;2011:213848. doi: 10.1155/2011/213848

Figure 3.

Figure 3

Cisplatin half-life (■) and the corresponding percent of increased lifespan (%ILS) (gray square) from the P388 murine lymphocytic leukemia model are plotted as a function of the liposomal membrane composition. Mice (n = 8) bearing P388 tumors received intravenous injections of liposomal cisplatin formulations at MTD doses on a Q4D × 3 dosing schedule.